Peer-reviewedCC BYJournal of shoulder and elbow arthroplasty
Evaluating the safety of glucagon-like peptide-1 agonist use in non-diabetic overweight patients undergoing shoulder arthroplasty
Related
- Glucagon-like peptide-1 receptor agonists in diabetic patients with heart failure with reduced ejection fraction - real world outcomes
- Clinical and Patient-Reported Outcomes in Non-English-Speaking Patients Undergoing Primary Total Knee Arthroplasty
- The Sacro-Femoral-Pubic Angle May Estimate Pelvic Tilt in Patients with Severe Developmental Dysplasia of the Hip and Leg Length Discrepancy Undergoing Total Hip Arthroplasty
- Association between Perioperative Blood Glucose Levels and Wound Complications in Diabetic Patients Undergoing Adult Spinal Deformity Surgery: A Retrospective Cohort Study
- Salivary gland dynamic imaging combined with tomosynthesis fusion imaging for evaluating postoperative salivary gland function changes in patients with differentiated thyroid cancer undergoing initial 131I therapy
BibTeX
@article{anon2026evaluating,
title = {{Evaluating the safety of glucagon-like peptide-1 agonist use in non-diabetic overweight patients undergoing shoulder arthroplasty}},
journal = {Journal of shoulder and elbow arthroplasty},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13675852},
note = {CC BY},
}
RIS
TY - JOUR
TI - Evaluating the safety of glucagon-like peptide-1 agonist use in non-diabetic overweight patients undergoing shoulder arthroplasty
PY - 2026
DA - 2026/09/09
JO - Journal of shoulder and elbow arthroplasty
UR - https://europepmc.org/article/PMC/PMC13675852
SN - 2471-5492
ER -